| 000 | 01589 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513120216.0 | ||
| 264 | 0 | _c19970605 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0007-1331 | ||
| 024 | 7 |
_a10.1046/j.1464-410x.1997.00142.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAli-el-Dein, B | |
| 245 | 0 | 0 |
_aSingle-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. _h[electronic resource] |
| 260 |
_bBritish journal of urology _cMay 1997 |
||
| 300 |
_a731-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xpathology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xpathology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xpathology |
| 700 | 1 | _aNabeeh, A | |
| 700 | 1 | _ael-Baz, M | |
| 700 | 1 | _aShamaa, S | |
| 700 | 1 | _aAshamallah, A | |
| 773 | 0 |
_tBritish journal of urology _gvol. 79 _gno. 5 _gp. 731-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1464-410x.1997.00142.x _zAvailable from publisher's website |
| 999 |
_c9139758 _d9139758 |
||